Page last updated: 2024-08-25

acamprosate and HIV Coinfection

acamprosate has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Akgün, K; Bryant, K; Crystal, S; Edelman, EJ; Fiellin, DA; Fiellin, LE; Gaither, JR; Gordon, AJ; Goulet, JL; Justice, AC; Korthuis, PT; Kraemer, KL; Marshall, BDL; McGinnis, KA; Oldfield, BJ; Williams, EC1
Chand, PK; Thirthalli, J1

Reviews

1 review(s) available for acamprosate and HIV Coinfection

ArticleYear
The implications of medication development in the treatment of substance use disorders in developing countries.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine

2009

Other Studies

1 other study(ies) available for acamprosate and HIV Coinfection

ArticleYear
Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
    Journal of substance abuse treatment, 2020, Volume: 109

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Naltrexone; Prevalence; Veterans

2020